Pulse Methylprednisolone Versus Dexamethasone in COVID-19: A Multicenter Cohort Study.

Atsuyuki Watanabe,Ryota Inokuchi,Toshiki Kuno,Kazuaki Uda,Jun Komiyama,Motohiko Adomi,Yoshiko Ishisaka,Toshikazu Abe,Nanako Tamiya,Masao Iwagami

Critical care explorations（2023）

引用 0|浏览4

暂无评分

摘要

Higher doses of pulse methylprednisolone (500 or 1,000 mg/d) may be associated with worse COVID-19 outcomes when compared with dexamethasone, especially in patients not on IMV.

查看译文

关键词

COVID-19,dexamethasone,methylprednisolone,mortality,pulse therapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要